Regeneron Ventures, a Greenwich, Conn.-based biotech focused venture capital firm, announced its launch.
Regeneron Pharmaceuticals is the fund’s exclusive limited partner and has committed $100m annually for five years.
Read more on VCWire.tech, our new website dedicated to the tech venture capital industry.
FinSMEs
16/04/2024